Literature DB >> 7861872

Ethics of n-of-1 trials.

L Irwig1, P Glasziou, L March.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1995        PMID: 7861872     DOI: 10.1016/s0140-6736(95)90578-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Ethics review roulette: what can we learn?

Authors:  Paul Glasziou; Iain Chalmers
Journal:  BMJ       Date:  2004-01-17

2.  N of 1 trials in diabetes: making individual therapeutic decisions.

Authors:  A Tsapas; D R Matthews
Journal:  Diabetologia       Date:  2008-04-04       Impact factor: 10.122

Review 3.  Overcoming implementation challenges of personalized cancer therapy.

Authors:  Funda Meric-Bernstam; Gordon B Mills
Journal:  Nat Rev Clin Oncol       Date:  2012-07-31       Impact factor: 66.675

4.  Randomised study of n of 1 trials versus standard practice.

Authors:  J Mahon; A Laupacis; A Donner; T Wood
Journal:  BMJ       Date:  1996-04-27

5.  N of 1, two contemporary arm, randomised controlled clinical trial for bilateral epicondylitis: a new study design.

Authors:  Luigia Scudeller; Claudia Del Fante; Cesare Perotti; Claudio Francesco Pavesi; Davide Coscia; Valeria Scotti; Carmine Tinelli
Journal:  BMJ       Date:  2011-12-20

6.  Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

Authors:  Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt
Journal:  BMC Neurol       Date:  2015-03-25       Impact factor: 2.474

7.  N-of-1 Design and Its Applications to Personalized Treatment Studies.

Authors:  Tailiang Xie; Zhuoxin Yu
Journal:  Stat Biosci       Date:  2016-09-06

8.  Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.

Authors:  Fanny M Elahi; Gabe Marx; Yann Cobigo; Adam M Staffaroni; John Kornak; Duygu Tosun; Adam L Boxer; Joel H Kramer; Bruce L Miller; Howard J Rosen
Journal:  Neuroimage Clin       Date:  2017-09-14       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.